Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025
2024's 'Biggest Loses' That Could See Reversal in 2025
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Merck Downgraded by BMO Over Keytruda Concerns
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Merck & Co Analyst Ratings
The Analyst Verdict: Incyte In The Eyes Of 15 Experts
IShares Genomics Immunology and Healthcare ETF Declares $0.1111 Dividend
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Stock Of The Day: Where Does The Merck Downtrend End?
Trump's tariff plan is unpopular! More than half of the USA population opposes imposing taxes on commodities from Mexico.
①The plan of the USA's incoming president Trump to impose tariffs does not seem to be popular among the public. According to a poll, 51% of USA voters oppose imposing tariffs on commodities from Mexico, Canada, and China; ②Standard & Poor's states that USA tariffs will increase inflation rates and reduce economic output, while some citizens and businesses are stockpiling goods due to tariff concerns, leading to a significant increase in throughput at the ports of Los Angeles and Long Beach in November.
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Peering Into Exelixis's Recent Short Interest
10 Health Care Stocks With Whale Alerts In Today's Session
Dow's Drop: How Blue-chips Have Fared During Index's Peak Turned Worst-run in Decades
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Merck-Hansoh Deal for Oral GLP-1 Hurts Obesity Drug Developers